首页> 美国卫生研究院文献>Cancer Genomics Proteomics >Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: MYOD1-mutation and Clonal Evolution
【2h】

Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity: MYOD1-mutation and Clonal Evolution

机译:肢体成人硬化脉络膜瘤瘤的细胞遗传学和分子研究:Myod1-突变和克隆演化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Spindle cell/sclerosing rhabdo-myosarcoma is a genomically heterogeneous, uncommon subtype of rhabdomyosarcoma, particularly rare in adults. Its MYOD1-mutant variant is aggressive irrespective of age. Cytogenetic data on spindle cell/sclerosing rhabdomyosarcoma are sparse and disparate. Materials and Methods: Cytogenetic and molecular analyses were performed on an adult sclerosing rhabdomyosarcoma. Results: The karyotype of the sclerosing rhabdomyosarcoma displayed clonal evolution corresponding to two hyperdiploid clones: 48,XY,+i(19)(p10),+22/ 48,idem,der(9)t(2;9)(q21~22;p21). The changes were gain of chromosome 19 with the overrepresentation of 19p arm, gain of chromosome 22, gain of the 2q arm, and loss of 9p21. Mutation analysis revealed a homozygous c.T365G (p.L122R) mutation of the MYOD1 gene, but none of PIK3CA. Conclusion: To our knowledge, this is the first adult MYOD1-mutant sclerosing rhabdomyosarcoma studied cytogenetically. The only other reported sclerosing rhabdomyosarcoma with MYOD1 mutation and abnormal karyotype was pediatric. Since these tumors are highly aggressive, further studies unravelling their cytogenetic and molecular characteristics are warranted.
机译:背景:主轴细胞/硬化rhabdo-myosarcoma是一种基因组异质,横伤的罕见亚型,在成年人中特别罕见。它的Myod1-突变体变体与年龄无关侵略性。主轴细胞/硬化横纹肌肉瘤的细胞遗传学数据稀疏和不同。材料和方法:在成人硬化横纹肌肉瘤中进行细胞遗传学和分子分析。结果:硬质横纹肌肉瘤的核型显示克隆演化对应于两个高倍体克隆:48,XY,+ I(19)(P10),+ 22/48,IDEM,DER(9)T(2; 9)(Q21〜 22; p21)。随着19P臂的过度陈述,染色体22的增益,2Q臂的增益以及9p21的损失,变化是染色体19的增益。突变分析揭示了Myod1基因的纯合C.T365G(P.L122R)突变,但均不为PIK3CA。结论:对我们的知识,这是第一个成年肌腱1-突变体硬化横纹肌肉瘤学习过细胞瘤。唯一报告的横血管骨肉瘤与Myod1突变和异常核型是小儿科。由于这些肿瘤是高度侵略性的,因此需要进一步研究其细胞遗传学和分子特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号